» Articles » PMID: 31548227

Liver Tropism in Cancer: The Hepatic Metastatic Niche

Overview
Specialty General Medicine
Date 2019 Sep 25
PMID 31548227
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The liver is the largest organ in the human body and is prone for cancer metastasis. Although the metastatic pattern can differ depending on the cancer type, the liver is the organ to which cancer cells most frequently metastasize for the majority of prevalent malignancies. The liver is unique in several aspects: the vascular structure is highly permeable and has unparalleled dual blood connectivity, and the hepatic tissue microenvironment presents a natural soil for the seeding of disseminated tumor cells. Although 70% of the liver is composed of the parenchymal hepatocytes, the remaining 30% is composed of nonparenchymal cells including Kupffer cells, liver sinusoidal endothelial cells, and hepatic stellate cells. Recent discoveries show that both the parenchymal and the nonparenchymal cells can modulate each step of the hepatic metastatic cascade, including the initial seeding and colonization as well as the decision to undergo dormancy versus outgrowth. Thus, a better understanding of the molecular mechanisms orchestrating the formation of a hospitable hepatic metastatic niche and the identification of the drivers supporting this process is critical for the development of better therapies to stop or at least decrease liver metastasis. The focus of this perspective is on the bidirectional interactions between the disseminated cancer cells and the unique hepatic metastatic niche.

Citing Articles

The role of macrophages in liver metastasis: mechanisms and therapeutic prospects.

Yuan Q, Jia L, Yang J, Li W Front Immunol. 2025; 16:1542197.

PMID: 40034694 PMC: 11872939. DOI: 10.3389/fimmu.2025.1542197.


Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review).

Jin Z, Li Y, Yi H, Wang M, Wang C, Du S Int J Oncol. 2025; 66(3).

PMID: 39950314 PMC: 11844340. DOI: 10.3892/ijo.2025.5728.


Impact of MRI Texture Analysis on Complication Rate in MRI-Guided Liver Biopsies.

Leonhardi J, Niebur M, Hohn A, Ebel S, Struck M, Tautenhahn H J Imaging Inform Med. 2025; .

PMID: 39934533 DOI: 10.1007/s10278-025-01439-0.


Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances.

Kulbay M, Tuli N, Mazza M, Jaffer A, Juntipwong S, Marcotte E Biomedicines. 2025; 13(1).

PMID: 39857692 PMC: 11762644. DOI: 10.3390/biomedicines13010108.


The Role of Myeloid Cells on the Development of Hepatic Metastases in Gastrointestinal Cancer.

Dosch A, Martos M, Singh S, Kodia K, Merchant N, Nagathihalli N Gastro Hep Adv. 2025; 4(1):100538.

PMID: 39790246 PMC: 11714404. DOI: 10.1016/j.gastha.2024.08.017.


References
1.
Wang H, McIntosh A, Hasinoff B, Rector E, Ahmed N, Nance D . B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res. 2000; 60(20):5862-9. View

2.
Poisson J, Lemoinne S, Boulanger C, Durand F, Moreau R, Valla D . Liver sinusoidal endothelial cells: Physiology and role in liver diseases. J Hepatol. 2016; 66(1):212-227. DOI: 10.1016/j.jhep.2016.07.009. View

3.
He Z, Ong C, Halper J, Bateman A . Progranulin is a mediator of the wound response. Nat Med. 2003; 9(2):225-9. DOI: 10.1038/nm816. View

4.
Khatib A, Fallavollita L, Wancewicz E, Monia B, Brodt P . Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res. 2002; 62(19):5393-8. View

5.
Steele C, Karim S, Leach J, Bailey P, Upstill-Goddard R, Rishi L . CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2016; 29(6):832-845. PMC: 4912354. DOI: 10.1016/j.ccell.2016.04.014. View